Page last updated: 2024-10-21

vanilmandelic acid and Hemangioendothelioma

vanilmandelic acid has been researched along with Hemangioendothelioma in 1 studies

Vanilmandelic Acid: A 3-O-methyl ether of 3,4-dihydroxymandelic acid. It is an end-stage metabolite of CATECHOLAMINES; EPINEPHRINE; and NOREPINEPHRINE.
vanillylmandelic acid : An aromatic ether that is the 3-O-methyl ether of 3,4-dihydroxymandelic acid.

Hemangioendothelioma: A neoplasm derived from blood vessels, characterized by numerous prominent endothelial cells that occur singly, in aggregates, and as the lining of congeries of vascular tubes or channels. Hemangioendotheliomas are relatively rare and are of intermediate malignancy (between benign hemangiomas and conventional angiosarcomas). They affect men and women about equally and rarely develop in childhood. (From Stedman, 25th ed; Holland et al., Cancer Medicine, 3d ed, p1866)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Seo, IS1
Min, KW1
Mirkin, LD1

Other Studies

1 other study available for vanilmandelic acid and Hemangioendothelioma

ArticleYear
Hepatic hemangioendothelioma of infancy associated with elevated alpha fetoprotein and catecholamine by-products.
    Pediatric pathology, 1988, Volume: 8, Issue:6

    Topics: alpha-Fetoproteins; Antigens; Factor VIII; Female; Follow-Up Studies; Hemangioendothelioma; Homovani

1988